Vinge has advised Autoliv, Inc. (“Autoliv”) and Veoneer, Inc. (“Veoneer”) in connection with the spin-off and listing of Veoneer on the New York Stock Exchange and Nasdaq Stockholm. First day of regular trading of Veoneer was July 2, 2018.
Vinge advises Calliditas Therapeutics AB (publ) (“Calliditas Therapeutics”) in connection with the listing of the company’s shares on Nasdaq Stockholm’s main market. Trading in Calliditas Therapeutics’ shares on Nasdaq Stockholm commences today, 29 June 2018.
Vinge advises Net Gaming Europe AB (publ) in connection with its list change from Spotlight Stock Market (previously AktieTorget) to Nasdaq First North Premier.
Vinge advises Danske Bank A/S, Danmark, Sverige Filial and Skandinaviska Enskilda Banken (publ) who are acting as Joint Global Coordinators and Joint Bookrunners in connection with the listing of Raketech Group Holding plc – a marketing actor whose primary business involves using its online products to influence iGaming market users who are interested in sports and gambling and to guide them towards the best gambling services – on Nasdaq First North Premier.
Vinge advises Nordea Bank AB (publ) and Skandinaviska Enskilda Banken (publ) who are acting as Joint Global Coordinators and Joint Bookrunners in connection with the listing of Better Collective A/S – one of the leading affiliates on the European iGaming affiliate market – on Nasdaq Stockholm.
Vinge has advised Cellink AB (publ) in connection with a directed new issue of shares to Swedish and internationally well-reputed investors such as the Swedish Fourth AP Fund (AP4), Carl Bennet AB, Claes Dinkelspiel and Handelsbanken Fonder.
Opus Group AB (publ) (”Opus”) has issued a so called senior unsecured bond in the amount of MSEK 500 MSEK with a term of four years on the Nordic market.
Tele2 AB (publ) and Com Hem Holding AB (publ) announced on 10 January 2018 that they have agreed on a combination through a statutory merger in accordance with the Swedish Companies Act.
The board of directors of Hansa Medical has resolved on a directed new issue of ordinary shares, subject to approval by an extraordinary general meeting, whereby Hansa Medical will raise proceeds of approximately SEK 545 million, before issue costs.
Vinge advises DGC One AB (publ) (“DGC”) in connection with EQT’s acquisition of 85.2 percent of the total number of shares and votes in DGC and subsequent mandatory recommended cash offer to the remaining shareholders.
